HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Possible mechanisms underlying development of transfusion-related acute lung injury: roles of anti-major histocompatibility complex class II DR antibody.

Abstract
Anti-major histocompatibility complex (anti-MHC) antibodies (Abs) and antipolymorphonuclear neutrophil (anti-PMN) Abs are generally considered as the main causes of the development of transfusion-related acute lung injury (TRALI), which is one of the most severe and sometimes lethal side effects of transfusion. These Abs are postulated to activate recipient's leucocytes, resulting in the release of soluble factors such as reactive oxygen species and detrimental cytokines and chemokines. The harmful effects on the lung tissues and resident leucocytes of these malignant factors are suspected to be profoundly involved in TRALI reactions. Several reports have indicated the principle effect of biologically active lipids on the pathogenesis of TRALI. However, the precise mechanisms of TRALI development remain unclear. To resolve this issue, we have been investigating cytokines that induce continuous inflammation of the lungs, specifically focusing on the cytokines derived from activated PMNs. We observed that the granulocyte-macrophage colony-stimulating factor (GM-CSF) markedly enhances the expression of MHC class II DR in PMNs. Moreover, MHC class II DR-expressing PMNs were also proved to express a high-affinity receptor for immunoglobulin E (IgE) (FcepsilonRI) and to produce tumour necrosis factor-alpha, interferon-gamma and interleukin-18 following a challenge with an anti-MHC class II DR monoclonal Ab (MoAb) or anti-DR antiserum. It is strongly suggested that amongst various inflammatory mediators, at least these three cytokines may contribute to the duration of inflammatory reactions in the lungs. Furthermore, FcepsilonRI expression, in GM-CSF-treated PMNs, suggests the involvement of PMNs in IgE-mediated immune reactions.
AuthorsM Nishimura, S Mitsunaga, Y Ishikawa, M Satake
JournalTransfusion medicine (Oxford, England) (Transfus Med) Vol. 13 Issue 3 Pg. 141-7 (Jun 2003) ISSN: 0958-7578 [Print] England
PMID12791081 (Publication Type: Journal Article)
Chemical References
  • Cytokines
  • HLA-DR Antigens
  • Isoantibodies
  • Receptors, IgE
  • Granulocyte-Macrophage Colony-Stimulating Factor
Topics
  • Cytokines (biosynthesis)
  • Granulocyte-Macrophage Colony-Stimulating Factor (pharmacology)
  • HLA-DR Antigens (analysis, biosynthesis, immunology)
  • Humans
  • Inflammation (etiology)
  • Isoantibodies (immunology, pharmacology)
  • Neutrophil Activation (immunology)
  • Receptors, IgE (biosynthesis)
  • Respiratory Distress Syndrome (etiology, immunology)
  • Transfusion Reaction
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: